Gujarat Themis Biosyn informs about transcript of conference call

10 Nov 2023 Evaluate

Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to its letter dated 31st October, 2023, intimating about the earning conference call for Q2 & H1 FY 23-24 with Analysts/Investors held on 7th November, 2023, Gujarat Themis Biosyn has informed that it attached the transcript of the aforesaid conference call. The above information is also available on the website of the Company at https://www.gtbl.in/investor-meet-transcripts/.

The above information is a part of company’s filings submitted to BSE.


Guj. Themis Biosyn Share Price

402.70 4.20 (1.05%)
13-May-2024 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5913.95
Cipla 1421.00
Zydus Lifesciences 993.40
Lupin 1684.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.